Evidence map›Paper›PMID 33109637›Full record

ArticleBMJ open2020

Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study.

Easter Elizabeth Olwanda, James G Kahn, Yujung Choi, Jessica Yasmine Islam, Megan Huchko

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02124252 (Evaluation of a Community-Driven Cervical Cancer Prevention Strategy in Western Kenya), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02124252 nacompletednot on this map

Evaluation of a Community-Driven Cervical Cancer Prevention Strategy in Western Kenya

TypeinterventionalSponsorDuke UniversityRan2016 to 2019Enrolled7,200ConditionsHuman Papilloma Virus Infection, Carcinoma in Situ of Uterine CervixArmsCommunity-based testing with standard linkage to care, Community-based HPV testing with enhanced linkage to care
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Easter Elizabeth OlwandaCenter for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya eolwanda@gmail.com.ORCID 0000-0002-3158-9415
James G KahnDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Yujung ChoiDuke Global Health Institute, Duke University, Durham, NC, USA.
Jessica Yasmine IslamDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-3690-3848
Megan HuchkoDuke Global Health Institute, Duke University, Durham, NC, USA.
Duke University · USKenya Medical Research Institute · KEUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · US

Funding

Evaluating a community-driven cervical cancer prevention model in western KenyaR01CA188428 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUCHKO, MEGAN J. · 2014 to 2018
$2.5M
NCI NIH HHS R01 CA188428
6 · The paper itself

Abstract

objectivesTo estimate the cost of human papillomavirus (HPV)-based screening through community health campaigns (CHCs) and home-based testing.

settingCHCs and home-based testing in six communities in rural Western Kenya.

participantsCHCs and home-based screening reached 2297 and 1002 women aged 25-65 years, respectively. OUTCOME MEASURES: Outcome measures were overall cost per woman screened achieved through the CHCs and home-based testing and the cost per woman for each activity comprising the screening intervention.

resultsThe mean cost per woman screened through CHCs and home-based testing were similar, at $37.7 (range $26.4-$52.0) and $37.1 (range $27.6-$54.0), respectively. For CHCs, personnel represented 49% of overall cost, supplies 25%, services 5% and capital goods 23%. For home-based testing, these were: personnel 73%, supplies 25%, services 1% and capital goods 2%. A greater number of participants was associated with a lower cost per participant.

conclusionsThe mean cost per woman screened is comparable for CHC and home-based testing, with differences in type of input. The CHCs generally reached more eligible women in the six communities, whereas home-based strategies more efficiently reached populations with low screening rates. TRIAL REGISTRATION NUMBER: NCT02124252.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsAdultAgedEarly Detection of CancerFemaleHumansKenyaMass ScreeningMiddle AgedPublic Healthcervical cancercommunity health campaignshome-based testinghuman papillomavirusmicro-costingrural Kenya

Identifiers

PMID33109637
PMCPMC7592277
OpenAlexW3095542409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.